好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Infections

Wednesday 04/13/11
01:00 PM - 02:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Infections/AIDS/Prion Disease
No CME available
Event Timeline
01:00 PM - 02:45 PM Abstract 001 - Increased Neurologic Disease Burden and Risk of Death in HIV-Infected Individuals with Hepatitis C Co-Infection
01:00 PM - 02:45 PM Abstract 002 - The Development of an Effective Diagnostic Algorithm for Encephalitis
01:00 PM - 02:45 PM Abstract 003 - Pediatric Neurological Complications of 2009 Pandemic Influenza A (H1N1)
01:00 PM - 02:45 PM Abstract 004 - Survival Analysis of Human T-Lymphotropic Virus 1 Associated Myelopathy: A 78-Patient Follow-Up Study
01:00 PM - 02:45 PM Abstract 005 - HIV-Tat Protein Forms an Immune Complex, Binds the NMDA Receptor, and Prevents Receptor Activation and Excitotoxicity: Implications for HIV Neurocognitive Dysfunction
01:00 PM - 02:45 PM Abstract 007 - Predictors of Symptomatic HIV-Associated Neurocognitive Disorders in the cART Era: A Longitudinal Cohort Study
Faculty Disclosures
Avindra Nath, MD, MBBS, FAAN The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Stephen M. Newman, MD Dr. Newman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme . Dr. Newman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen.
Samuel J. Potolicchio, Jr., MD No disclosure on file
William R. Tyor, MD, FAAN The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH.
Cheryl A. Jay, MD, FAAN No disclosure on file
Christopher Power, MD Dr. Power has nothing to disclose.
Julie A. Parsons, MD Dr. Parsons has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenex. The institution of Dr. Parsons has received research support from AveXis. The institution of Dr. Parsons has received research support from Biogen. The institution of Dr. Parsons has received research support from Scholar Rock. The institution of Dr. Parsons has received research support from Biohaven. The institution of Dr. Parsons has received research support from PTC Therapeutics. The institution of Dr. Parsons has received research support from Novartis.
Amy R. Brooks-Kayal, MD, FAAN Dr. Brooks-Kayal has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brooks-Kayal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Brooks-Kayal has stock in Johnson and Johnson. The institution of Dr. Brooks-Kayal has received research support from NINDS.
Sanjeev V. Kothare, MD, FAAN Dr. Kothare has nothing to disclose.
Abelardo Q. Araujo, MD, PhD, MSc No disclosure on file
James J. Sejvar, MD, FAAN Dr. Sejvar has nothing to disclose.
Annapurna Poduri, MD, MPH An immediate family member of Dr. Poduri has received personal compensation for serving as an employee of Beam Therapeutics. An immediate family member of Dr. Poduri has stock in Beam Therapeutics. The institution of Dr. Poduri has received research support from NIH.
Jeffrey Rumbaugh, MD No disclosure on file
Arun Venkatesan, MD, PhD Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from MSRCF. The institution of Dr. Venkatesan has received research support from U.S. DOD.
Fabiana C. Souza-Lima, MD No disclosure on file
Daniel D. Bezerra, MD No disclosure on file
No disclosure on file
Jennifer McCombe, MD Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon therapeutics. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon therapeutics. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a traveling fellow with Royal College of Canada.
Teri Schreiner, MD, MPH, FAAN The institution of Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CDC. Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schreiner has received research support from Roche Genentech.
Marco Lima No disclosure on file
Britt A. Stroud, MD No disclosure on file
Sita Kedia, MD No disclosure on file
Tariq B. Alfahad, MD No disclosure on file
Gita Byraiah, MHS No disclosure on file
Pornpun Vivithanaporn No disclosure on file
Puja A. Joshi, MD No disclosure on file
Fatemah Alshawaf, MD Dr. Alshawaf has nothing to disclose.
Amanda K. Adcock No disclosure on file